Cargando…

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy

BACKGROUND: Initial prostate biopsy often fails to identify prostate cancer resulting in patient anxiety, especially when clinical features such as prostate specific antigen (PSA) remain elevated, leading to the need for repeat biopsies. Prostate biomarker tests, such as the ExoDx™ Prostate (Intelli...

Descripción completa

Detalles Bibliográficos
Autores principales:	McKiernan, James, Noerholm, Mikkel, Tadigotla, Vasisht, Kumar, Sonia, Torkler, Phillipp, Sant, Grannum, Alter, Jason, Donovan, Michael J., Skog, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466797/ https://www.ncbi.nlm.nih.gov/pubmed/32873277 http://dx.doi.org/10.1186/s12894-020-00712-4

Ejemplares similares

Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2–10 ng/mL
por: Tutrone, Ronald, et al.
Publicado: (2020)

Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcome
por: Kretschmer, Alexander, et al.
Publicado: (2022)

Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies
por: Margolis, Erik, et al.
Publicado: (2021)

Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy
por: Kretschmer, Alexander, et al.
Publicado: (2022)

Exosome-based liquid biopsies in cancer: opportunities and challenges
por: Yu, W., et al.
Publicado: (2021)

Clinical Value of a Routine Urine Culture Prior to Transrectal Prostate Biopsy
por: Örtegren, Joakim, et al.
Publicado: (2022)

Prevention of sepsis prior to prostate biopsy
por: Toner, Liam, et al.
Publicado: (2016)

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis
por: Tutrone, Ronald, et al.
Publicado: (2023)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Patient experience after transperineal template prostate biopsy compared to prior transrectal ultrasound guided prostate biopsy
por: Bhatt, Nikita R., et al.
Publicado: (2017)

Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer
por: Motamedinia, Piruz, et al.
Publicado: (2016)

Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
por: Nilsson, J, et al.
Publicado: (2009)

Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients
por: Ryoo, Hyunsoo, et al.
Publicado: (2020)

Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer
por: Alijaj, Nagjie, et al.
Publicado: (2022)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

Biopsy interpretation of the prostate
por: Epstein, Jonathan I.

Prostate biopsy interpretation
por: Epstein, Jonathan I.

Positive Culture Prior to Transperineal Prostate Biopsy Was Not Associated with Post-Biopsy Febrile Urinary Tract Infection Development
por: Tohi, Yoichiro, et al.
Publicado: (2021)

Microbiota of Urine, Glans and Prostate Biopsies in Patients with Prostate Cancer Reveals a Dysbiosis in the Genitourinary System
por: Gonçalves, Micael F. M., et al.
Publicado: (2023)

Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patients
por: Castellanos-Rizaldos, Elena, et al.
Publicado: (2019)

Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy
por: Shoskes, Daniel A, et al.
Publicado: (2015)

The Severity of Pain in Prostate Biopsy Depends on the Biopsy Sector
por: Rempega, Grzegorz, et al.
Publicado: (2023)

Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis
por: Hupe, Marie Christine, et al.
Publicado: (2018)

The use of prostate MR for targeting prostate biopsies
por: Kelley, R. Phelps, et al.
Publicado: (2019)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

Emerging Role of Exosomes in Liquid Biopsy for Monitoring Prostate Cancer Invasion and Metastasis
por: Gao, Zhengfan, et al.
Publicado: (2021)

Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
por: Balaban, Muhsin, et al.
Publicado: (2020)

Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery
por: Lee, Bongyong, et al.
Publicado: (2020)

Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications
por: Altay, Mehmet Sefa, et al.
Publicado: (2022)

Prostate Biopsy in the Case of PIRADS 5—Is Systematic Biopsy Mandatory?
por: Malewski, Wojciech, et al.
Publicado: (2023)

Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study)
por: Woo, Henry H., et al.
Publicado: (2022)

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies
por: Lantz, Anna, et al.
Publicado: (2020)

Editorial Comment: Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
por: Diniz, Andre Luiz Lima
Publicado: (2020)

Paradigm Shift in Prostate Cancer Diagnosis: Pre-Biopsy Prostate Magnetic Resonance Imaging and Targeted Biopsy
por: Park, Jung Jae, et al.
Publicado: (2022)

The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy
por: Lee, Chung Un, et al.
Publicado: (2021)

Hundred years of transperineal prostate biopsy
por: Schmeusser, Benjamin, et al.
Publicado: (2022)

Prostate biopsy approach and complication rates
por: Mate, Kinga, et al.
Publicado: (2023)

Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2022)

Comparison of the complications of traditional 12 cores transrectal prostate biopsy with image fusion guided transperineal prostate biopsy
por: Huang, Haifeng, et al.
Publicado: (2016)

Comparison of a Personalized Prostate Biopsy Pattern With Traditional Transrectal Prostate Biopsy: Different Cancer Detection Rate
por: Jiang, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kch41vnfor8kb7jj06dsnio0c4